Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-076776
Filing Date
2011-08-12
Accepted
2011-08-12 15:24:56
Documents
13
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c17919e10vq.htm 10-Q 574661
2 EXHIBIT 10.1 c17919exv10w1.htm EX-10.1 309348
3 EXHIBIT 10.2 c17919exv10w2.htm EX-10.2 14228
4 EXHIBIT 31.1 c17919exv31w1.htm EX-31.1 9625
5 EXHIBIT 31.2 c17919exv31w2.htm EX-31.2 9431
6 EXHIBIT 32.1 c17919exv32w1.htm EX-32.1 3129
7 EXHIBIT 32.2 c17919exv32w2.htm EX-32.2 3175
13 GRAPHIC c17919c1791901.gif GRAPHIC 1616
  Complete submission text file 0000950123-11-076776.txt   2514488

Data Files

Seq Description Document Type Size
8 EX-101 INSTANCE DOCUMENT cycc-20110630.xml EX-101.INS 241136
9 EX-101 SCHEMA DOCUMENT cycc-20110630.xsd EX-101.SCH 13732
10 EX-101 CALCULATION LINKBASE DOCUMENT cycc-20110630_cal.xml EX-101.CAL 42012
11 EX-101 LABELS LINKBASE DOCUMENT cycc-20110630_lab.xml EX-101.LAB 144729
12 EX-101 PRESENTATION LINKBASE DOCUMENT cycc-20110630_pre.xml EX-101.PRE 83351
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 111031110
SIC: 2834 Pharmaceutical Preparations